For citations:

Shestakova M.V., Galstyan G.R., Grineva E.N., Zilov A.V., Demidova T.Yu., Mkrtumyan A.M., Petunina N.A., Ruyatkina L.A., Sukhareva O.Y., Suplotova L.A., Shamkhalova M.S. The role of canagliflozin in the prevention of stroke and chronic kidney disease in patients with type 2 diabetes mellitus: an expert council resolution. Diabetes mellitus. 2023;26(5):484-491. (In Russ.) https://doi.org/10.14341/DM13086